MedTrace Logo

Identifying and Measuring Depression in Older Cancer Patients

NCT02174055 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 329

Last updated 2026-04-07

No results posted yet for this study

Summary

The purpose of this study is to develop an accurate and useful way of measuring older patients' moods and reactions to the combined issue of cancer treatment and aging. Also, the purpose of this study is to test a new self-report measure of depressive symptoms tailored to the needs of older adults with cancer. Findings from this research will help us develop improved methods of diagnosis and treatment.

Conditions

  • Older Cancer Patients

Interventions

BEHAVIORAL

Patient Interviews

participate in a brief interview

BEHAVIORAL

newly developed questionnaire

10-16 patients will review draft items and participate in a cognitive interview. 15 older patients will complete the draft measure in order to generate preliminary psychometric data. All interviews will be audio recorded and transcribed by Ubiqus Transcription Company. The audio recordings are uploaded through Ubiqus's secure server and the transcribed audio is returned to the research staff within 48 hours.

BEHAVIORAL

Pilot Testing the Draft Measure

The draft measure (approximately 35 items, described above) will be administered to a large sample of older cancer patients (n=150) to generate data to evaluate preliminary psychometric properties (item properties including measures of central tendency, skewness/kurtosis, internal consistency, test/re-test reliability, and construct validity (i.e, convergent and discriminant).and known group differences) to further winnow the measure to include approximately 20 items.

Sponsors & Collaborators

Principal Investigators

  • Rebecca Saracino, PhD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-20
Primary Completion
2027-06-30
Completion
2027-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02174055 on ClinicalTrials.gov